Invention Application
- Patent Title: CELLULAR IMMUNOTHERAPY FOR REPETITIVE ADMINISTRATION
-
Application No.: US16625678Application Date: 2018-07-02
-
Publication No.: US20220233588A1Publication Date: 2022-07-28
- Inventor: David SOURDIVE , Aymeric DUCLERT , Mathieu SIMON , Philippe DUCHATEAU , Alan Marc WILLIAMS , Laurent POIROT
- Applicant: CELLECTIS
- Applicant Address: FR PARIS
- Assignee: CELLECTIS
- Current Assignee: CELLECTIS
- Current Assignee Address: FR PARIS
- Priority: DKPA201770542 20170630,EPPCT/EP2017/076798 20171019,EPPCT/EP2018/053343 20180209
- International Application: PCT/EP2018/067857 WO 20180702
- Main IPC: A61K35/17
- IPC: A61K35/17 ; C12Q1/6881
Abstract:
The present invention provides composition kits and methods for treating cancer in a human by immunotherapy using successive doses of CAR-T cells with no or reduced anamnestic immune reaction in one individual (P).
Public/Granted literature
- US12144825B2 Cellular immunotherapy for repetitive administration Public/Granted day:2024-11-19
Information query
IPC分类:
